Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study

Natsuko Ishida,Ayano Katsura,Koichi Takagaki,Hiroshi Arakawa,Tsutomu Shimada,Satoshi Mizuno,Yoshimichi Sai,Yukio Kato,Hiroyuki Nakamura,Yukio Suga,Ryo Matsushita
DOI: https://doi.org/10.1186/s12903-024-04667-y
2024-08-02
BMC Oral Health
Abstract:Background: Hyposalivation is treated using oral cholinergic drugs; however, systemic side effects occasionally lead to discontinuation of treatment. We aimed to investigate the effects of transdermal pilocarpine on the salivary gland skin on saliva secretion and safety in rats. Methods: Pilocarpine was administered to rats orally (0.5 mg/kg) or topically on the salivary gland skin (5 mg/body). Saliva volume, the number of sweat dots, and fecal weight were measured along with pilocarpine concentration in plasma and submandibular gland tissues. Results: Saliva volume significantly increased 0.5 h after oral administration and 0.5, 3, and 12 h after topical administration. Fecal weight and sweat dots increased significantly 1 h after oral administration; however, no changes were observed after topical application. The pilocarpine concentration in the submandibular gland tissues of the topical group was higher than that in the oral group at 0.5, 3, and 12 h of administration. Conclusions: Pilocarpine application to salivary gland skin persistently increased salivary volume in rats without inducing sweating or diarrhea. Transdermal pilocarpine applied to the skin over the salivary glands may be an effective and safe treatment option for hyposalivation.
What problem does this paper attempt to address?